Elucent Medical Marks 25,000 Lives Impacted Through EnVisio® TechnologyMINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce that more than 25,000 successful procedures have been performed using the EnVisio® In-Body Spatial Intelligence™ platform. This milestone reflects Elucent’s ongoing commitment to transforming breast cancer surgery through innovation; by providing smarter and more precise technology.
Elucent Medical Receives FDA Breakthrough Device Designation for EnVisio X1™ In-Body Spatial Intelligence™ SystemNext-generation localization platform marks paradigm shift in minimally invasive surgery, elevating precision in cancer care
Elucent Announces New Partnership With SurvivingBreastCancer.orgThe Medical Device Company Will Sponsor the Educational Organization to Expand Its Reach to Patients, Families, Caregivers
